Leukemoid reaction is a benign, reactive process with elevated LAP & no Philadelphia chromosome, unlike malignant CML.
Causes of Atypical Lymphocytes (Reactive Lymphocytes)
Atypical lymphocytes are activated immune cells, often seen in infections. Their unique look aids diagnosis, but distinguishing it from cancer is important.
Hypersensitivity Reactions: Causes and Mechanisms
Hypersensitivity is an exaggerated, undesirable immune response to an antigen, causing tissue damage. It encompasses four types: IgE-mediated (allergies), cytotoxic, immune complex, and delayed cell-mediated reactions.
Chediak-Higashi Syndrome
Chediak-Higashi syndrome (CHS) is a rare genetic disorder characterized by oculocutaneous albinism, immune deficiency, and neurological decline.
Diffuse Large B-Cell Lymphoma (DLBCL)
Learn about Diffuse Large B-Cell Lymphoma (DLBCL) and its diagnosis, treatment with R-CHOP, and management of relapsed disease.
Acute Lymphoblastic Leukemia or ALL
Acute Lymphoblastic Leukemia (ALL) is a cancer of immature white blood cells. Learn its cause, symptoms, and modern treatment, including CAR T-cell therapy.
Sjögren’s Syndrome
Sjögren’s syndrome: An autoimmune disease causing dry eyes, mouth. Systemic effects is possible. Early diagnosis & management are key.
Waldenström Macroglobulinemia
Waldenström Macroglobulinemia (WM): Rare lymphoma, excess IgM. Causes fatigue, neuropathy, & hyperviscosity. Early diagnosis & tailored treatment are key.
Dendritic Cells
Dendritic cells (DCs) process antigens & present them to T cells, triggering immune responses.
Natural Killer Cells
Natural Killer (NK) cells are vital immune cells that provide rapid defense against infections and cancer. They recognize and eliminate stressed or infected cells without prior sensitization, playing a key role in immunosurveillance.
Burkitt Lymphoma
Burkitt Lymphoma is a rare cancer affecting children and adults. Key symptoms include rapidly growing tumors, often in the jaw or abdomen.
Immunotherapy
Immunotherapy harnesses the body’s immune system to fight cancer. It offers a targeted approach with fewer side effects compared to traditional treatments, providing hope for many cancer patients





